Published in Shock on April 01, 1996
Lipopolysaccharide endotoxins. Annu Rev Biochem (2001) 18.88
Lipid A modification systems in gram-negative bacteria. Annu Rev Biochem (2007) 8.60
Naturally occurring lipid A mutants in neisseria meningitidis from patients with invasive meningococcal disease are associated with reduced coagulopathy. PLoS Pathog (2009) 1.08
Lipopolysaccharide induction of tissue factor expression in rabbits. Infect Immun (1999) 1.08
Purification and characterization of the lipid A disaccharide synthase (LpxB) from Escherichia coli, a peripheral membrane protein. Biochemistry (2009) 0.90
Upregulation of tissue factor in monocytes by cleaved high molecular weight kininogen is dependent on TNF-alpha and IL-1beta. Am J Physiol Heart Circ Physiol (2009) 0.83
Low-dose polymyxin: an option for therapy of Gram-negative sepsis. Innate Immun (2016) 0.75
Construction and characterization of amplifiable multicopy DNA cloning vehicles derived from the P15A cryptic miniplasmid. J Bacteriol (1978) 75.38
Nonchromosomal antibiotic resistance in bacteria: genetic transformation of Escherichia coli by R-factor DNA. Proc Natl Acad Sci U S A (1972) 57.06
Construction of biologically functional bacterial plasmids in vitro. Proc Natl Acad Sci U S A (1973) 25.61
Recircularization and autonomous replication of a sheared R-factor DNA segment in Escherichia coli transformants. Proc Natl Acad Sci U S A (1973) 13.45
Replication and transcription of eukaryotic DNA in Escherichia coli. Proc Natl Acad Sci U S A (1974) 10.51
Phenotypic expression in E. coli of a DNA sequence coding for mouse dihydrofolate reductase. Nature (1978) 8.76
Decay of mRNA in Escherichia coli: investigation of the fate of specific segments of transcripts. Proc Natl Acad Sci U S A (1983) 6.79
Nucleotide sequence of cloned cDNA for bovine corticotropin-beta-lipotropin precursor. Nature (1979) 6.56
Revised interpretation of the origin of the pSC101 plasmid. J Bacteriol (1977) 5.51
Genome construction between bacterial species in vitro: replication and expression of Staphylococcus plasmid genes in Escherichia coli. Proc Natl Acad Sci U S A (1974) 5.47
Structure and genomic organization of the mouse dihydrofolate reductase gene. Cell (1980) 4.25
Indirect selection of bacterial plasmids lacking identifiable phenotypic properties. J Bacteriol (1975) 3.88
Postoperative course and hemodynamic profile after the arterial switch operation in neonates and infants. A comparison of low-flow cardiopulmonary bypass and circulatory arrest. Circulation (1995) 3.80
Cloning and analysis of strong promoters is made possible by the downstream placement of a RNA termination signal. Proc Natl Acad Sci U S A (1981) 3.77
Isolation of histone genes from unfractionated sea urchin DNA by subculture cloning in E. coli. Nature (1975) 3.70
Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon. J Clin Invest (1987) 3.29
Studies of mouse mitochondrial DNA in Escherichia coli: structure and function of the eucaryotic-procaryotic chimeric plasmids. Cell (1975) 2.80
Expression of tissue factor, thrombomodulin, and E-selectin in baboons with lethal Escherichia coli sepsis. Am J Pathol (1993) 2.27
Outcome and assessment after the modified Fontan procedure for hypoplastic left heart syndrome. Circulation (1992) 2.15
Additional studies on human C5: development of a modified purification method and characterization of the purified product by polyacrylamide gel electrophoresis. Immunochemistry (1972) 2.10
Characterization of the structural gene and putative 5'-regulatory sequences for human proopiomelanocortin. Nature (1982) 2.04
Impact of encephalopathy on mortality in the sepsis syndrome. The Veterans Administration Systemic Sepsis Cooperative Study Group. Crit Care Med (1990) 2.04
Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock. J Clin Invest (1993) 2.00
Generation of chemotactic activity in rabbit serum by plasminogen-streptokinase mixtures. J Exp Med (1967) 1.90
A macrophage protein, Ym1, transiently expressed during inflammation is a novel mammalian lectin. J Biol Chem (2001) 1.88
Alterations in p53 and p16INK4 expression and telomere length during spontaneous immortalization of Li-Fraumeni syndrome fibroblasts. Mol Cell Biol (1995) 1.85
Incidental vesicoureteral reflux in neonates with antenatally detected hydronephrosis and other renal abnormalities. Radiology (1993) 1.83
Video-assisted thoracoscopic division of a vascular ring in an infant: a new operative technique. J Card Surg (1993) 1.82
Human protein C receptor is present primarily on endothelium of large blood vessels: implications for the control of the protein C pathway. Circulation (1997) 1.81
The endothelial cell protein C receptor aids in host defense against Escherichia coli sepsis. Blood (2000) 1.80
Comparison of gastrin and histamine on gastric mucosal blood flow. Proc Soc Exp Biol Med (1969) 1.73
Outcome of cardiopulmonary resuscitation in a pediatric cardiac intensive care unit. Crit Care Med (2000) 1.71
Impact of respiratory syncytial virus infection on surgery for congenital heart disease: postoperative course and outcome. Crit Care Med (1999) 1.66
Prognostic determinants in hypertrophic cardiomyopathy. Prospective evaluation of a therapeutic strategy based on clinical, Holter, hemodynamic, and electrophysiological findings. Circulation (1992) 1.63
A method for selective cloning of eukaryotic DNA fragments in Escherichia coli by repeated transformation. Mol Gen Genet (1974) 1.61
Two-stage response to endotoxin infusion into normal human subjects: Correlation of blood phagocyte luminescence with clinical and laboratory markers of the inflammatory, hemostatic response. Crit Care Med (2001) 1.61
Inflammation and coagulation: linked processes potentially regulated through a common pathway mediated by protein C. Thromb Haemost (1991) 1.59
One-stage repair of interrupted aortic arch, ventricular septal defect, and subaortic obstruction in the neonate: a novel approach. J Thorac Cardiovasc Surg (1996) 1.55
Endothelial cell protein C receptor plays an important role in protein C activation in vivo. Blood (2001) 1.51
Initiation of protein synthesis in bacteria at a translational start codon of mamalian cDNA: effects of the preceding nucleotide sequence. Proc Natl Acad Sci U S A (1980) 1.51
Genetic expression in bacteriophage lambda. 3. Inhibition of Escherichia coli nucleic acid and protein synthesis during lambda development. J Mol Biol (1970) 1.50
Emergent stent placement for acute Blalock-Taussig shunt obstruction after stage 1 Norwood surgery. Cathet Cardiovasc Diagn (1997) 1.50
Macromolecular enzymatic product of NAD+ in liver mitochondria. Proc Natl Acad Sci U S A (1975) 1.48
Chromatography, physical characteristics, and disulfide bonds of euglobulin plasminogen. Arch Biochem Biophys (1966) 1.47
Genomic amplification of MET with boundaries within fragile site FRA7G and upregulation of MET pathways in esophageal adenocarcinoma. Oncogene (2006) 1.47
Structural organization of human genomic DNA encoding the pro-opiomelanocortin peptide. Proc Natl Acad Sci U S A (1980) 1.44
Survival of primates in LD100 septic shock following therapy with antibody to tumor necrosis factor (TNF alpha). Circ Shock (1990) 1.39
The contact system contributes to hypotension but not disseminated intravascular coagulation in lethal bacteremia. In vivo use of a monoclonal anti-factor XII antibody to block contact activation in baboons. J Clin Invest (1993) 1.38
DEGR-factor Xa blocks disseminated intravascular coagulation initiated by Escherichia coli without preventing shock or organ damage. Blood (1991) 1.36
Endotoxin and cytokine profile in plasma of baboons challenged with lethal and sublethal Escherichia coli. Circ Shock (1991) 1.35
Effects of acetylsalicylic acid on the canine response to endotoxin. J Pharmacol Exp Ther (1967) 1.33
Genetic organization and functional analysis of the otn DNA essential for cell-wall polysaccharide synthesis in Vibrio cholerae O139. Mol Microbiol (1996) 1.30
The organization of sea urchin histone genes. Cell (1975) 1.28
Characterization of the baboon responses to Shiga-like toxin: descriptive study of a new primate model of toxic responses to Stx-1. Am J Pathol (1999) 1.27
Characteristics of tumor cell bioactivity in oncogenic osteomalacia. Mol Cell Endocrinol (1996) 1.25
gas7: A gene expressed preferentially in growth-arrested fibroblasts and terminally differentiated Purkinje neurons affects neurite formation. Proc Natl Acad Sci U S A (1998) 1.25
The crystal structure of a novel mammalian lectin, Ym1, suggests a saccharide binding site. J Biol Chem (2001) 1.23
Covalent modification of proteins by metabolites of NAD+. Proc Natl Acad Sci U S A (1976) 1.23
Constitutive activation of integrin alpha 4 beta 1 defines a unique stage of human thymocyte development. J Exp Med (1994) 1.18
The case for water-borne infectious hepatitis. Am J Public Health Nations Health (1966) 1.17
Cardiorespiratory and metabolic responses to liver E. coli and endotoxin in the monkey. J Appl Physiol (1969) 1.16
Comparison of Indium-111 platelet scintigraphy and two-dimensional echocardiography in the diagnosis of left ventricular thrombi. N Engl J Med (1982) 1.16
Recombinant human antithrombin III improves survival and attenuates inflammatory responses in baboons lethally challenged with Escherichia coli. Blood (2000) 1.15
Divergent inducible expression of P-selectin and E-selectin in mice and primates. Blood (1999) 1.14
Effects of endotoxin on pulmonary capillary permeability, ultrastructure, and surfactant. Surg Gynecol Obstet (1969) 1.14
Determinants of Legionella pneumophila contamination of water distribution systems: 15-hospital prospective study. Infect Control (1987) 1.14
Mesenteric vascular responses to endotoxin in the monkey and dog. Am J Physiol (1970) 1.12
Release of interleukin-12 in experimental Escherichia coli septic shock in baboons: relation to plasma levels of interleukin-10 and interferon-gamma. Blood (1996) 1.12
The pulmonary ultrastructure in septic shock. Exp Mol Pathol (1970) 1.12
Stanniocalcin 1 and 2 are secreted as phosphoproteins from human fibrosarcoma cells. Biochem J (2000) 1.10
Nitrification and denitrification processes related to waste water treatment. Adv Appl Microbiol (1975) 1.10
Effect of indomethacin in endotoxin shock in the dog. Proc Soc Exp Biol Med (1967) 1.09
A model for thrombin protection against endotoxin. Thromb Res (1984) 1.09
Rapid cardiopulmonary support for children with complex congenital heart disease. Ann Thorac Surg (2000) 1.08
Effectiveness of steroid/antibiotic treatment in primates administered LD100 Escherichia coli. Ann Surg (1981) 1.08
Survival of primates in LD100 septic shock following steroid/antibiotic therapy. J Surg Res (1980) 1.07
Qualitative description of factors involved in the retraction and lysis of dilute whole blood clots and in the aggregation and retraction of platelets. J Clin Invest (1970) 1.05
Continuous arteriovenous hemofiltration therapy for Staphylococcus aureus-induced septicemia in immature swine. Crit Care Med (1993) 1.05
Purification and characterization of streptokinase with studies of streptokinase activation of plasminogen. Biochemistry (1968) 1.05
Detection of the 'hyperdynamic state' of sepsis in the baboon during lethal E. coli infusion. J Trauma (1983) 1.04
Response of the subhuman primate in gram-negative septicemia induced by live Escherichia coli. Surg Gynecol Obstet (1971) 1.04
Comparison of canine responses to Escherichia coli organisms and endotoxin. Surg Gynecol Obstet (1968) 1.04
Effects of ouabain on splanchnic hemodynamics in the rhesus monkey. Am Heart J (1971) 1.03
Cerebrovascular accidents following the Fontan operation. Pediatr Neurol (1995) 1.03
Effect of C1 inhibitor on inflammatory and physiologic response patterns in primates suffering from lethal septic shock. J Immunol (1998) 1.03
Tissue factor pathway inhibitor and von Willebrand factor antigen levels in adult respiratory distress syndrome and in a primate model of sepsis. Am J Respir Crit Care Med (1995) 1.03
Continuous versus intermittent furosemide infusion in critically ill infants after open heart operations. Ann Thorac Surg (1997) 1.01
Effects of endotoxin on myocardial hemodynamics, performance, and metabolism. Am J Physiol (1971) 1.01
Responses of the baboon to live Escherichia coli organisms and endotoxin. Surg Gynecol Obstet (1977) 1.01
Prevention of death in endotoxin shock by glucose administration. Surg Gynecol Obstet (1974) 1.01
Lethal Staphylococcus aureus-induced shock in primates: prevention of death with anti-TNF antibody. J Trauma (1992) 1.00